Immunotherapy can impact the quality of life of both patients and carers through toxicities or indirectly through mechanisms such as stress, financial toxicity, or fatigue that limits participation in life activities. Supportive care resources and interventions are needed for those receiving immunotherapy to minimise negative impacts on quality of life, according to this recent study.
People living in Australia and New Zealand are now advised to apply sunscreen every day when the UV index is predicted to reach 3 or above, according to this recent study.
Glembatumumab vedotin had modest activity and an acceptable safety profile in patients with advanced melanoma who were refractory to checkpoint inhibitors and MEK/BRAF inhibition, according to this recent study.
Melanoma patients’ who are receiving immunotherapy and targeted therapyhave different perceptions about quality of life expectations, degree of anxiety and progression-free survival differ compared with their provider, according to this recent study. The study also suggests patients and providers exhibit a higher willingness to pay for combination immunotherapy treatment compared with BRAF/MEK inhibitors, influenced predominately by overall survival expectations.
According to this recent study, consistency in anatomical pathologist's diagnosis of thin melanoma compared to dyplastic naevus is low, likely to be due to the difficulty of this area and the experience of interpreters.
The YOVAL1.1 melanoma model is transplantable, immunogenic and sensitive to clinical therapies, making it a valuable platform to guide strategic development of combined targeted therapy and immunotherapy approaches in BRAFV600E melanoma, according to this recent study.
GenoMELPREDICT is a simple tool for predicting CDKN2A mutational status among melanoma patients from melanoma-prone families and can aid in counselling these patients towards genetic testing or cancer risk counselling, according to this recent study.
Skin cancer screening has an important primary prevention function when information on preventive behaviour is provided by the examining physician, according to this recent study.
The Health Promotion Agency has recently launched a new campaign, ‘What’s your look? – don’t make it #DumbBurn’. This campaign encourages young people to avoid getting sunburnt. It will run through until mid-March 2019.
Administration of dung beetle glycosaminoglycan, CaG increased survival time and decreased melanoma sizes in mice, in accordance with their inhibitory effects on cell growth ratio of melanoma B16F10, according to this recent study.